(Q38689600)

5 September 2017

1 reference

title

Brain microglia in psychiatric disorders (English)

1 reference

5 September 2017

0 references

4

Paola Dazzan

0 references

Anthony C Vernon

Anthony C Vernon

2

0 references

Valeria Mondelli

Valeria Mondelli

1

0 references

Federico Turkheimer

Federico Turkheimer

3

0 references

Carmine Pariante

Carmine M Pariante

5

0 references

publication date

25 April 2017

1 reference

5 September 2017

The Lancet Psychiatry

1 reference

5 September 2017

4

1 reference

5 September 2017

563-572

1 reference

5 September 2017

7

1 reference

Microglia: Architects of the Developing Nervous System

5 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Alterations in immune cells and mediators in the brain: it's not always neuroinflammation!

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

A polarizing question: do M1 and M2 microglia exist?

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

ATP mediates rapid microglial response to local brain injury in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Activation status of human microglia is dependent on lesion formation stage and remyelination in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Sequential activation of microglia and astrocyte cytokine expression precedes increased Iba-1 or GFAP immunoreactivity following systemic immune challenge

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Microglia activation is associated with IFN-α induced depressive-like behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Microglia of prefrontal white matter in suicide

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Translocator protein mediates the anxiolytic and antidepressant effects of midazolam.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Endotoxin-induced systemic inflammation activates microglia: [¹¹C]PBR28 positron emission tomography in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Combined [(18)F]DPA-714 micro-positron emission tomography and autoradiography imaging of microglia activation after closed head injury in mice

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

The methodology of TSPO imaging with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [¹¹C]PBR28 PET study

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Neuroinflammatory and morphological changes in late-life depression: the NIMROD study.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Neuroinflammation in bipolar disorder - A [(11)C]-(R)-PK11195 positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Neuroinflammation in schizophrenia-related psychosis: a PET study.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [(11)C]PBR28 PET Brain Imaging Study.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [18F]FEPPA.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [(11)C](R)-PK11195 positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[(11)C]PK11195 brain PET studies

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

The peripheral benzodiazepine receptor ligand PK11195 binds with high affinity to the acute phase reactant alpha1-acid glycoprotein: implications for the use of the ligand as a CNS inflammatory marker

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

MRI/MRS in neuroinflammation: methodology and applications

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Magnetic resonance imaging of myelin

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Free water elimination and mapping from diffusion MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

T1 and T2 relaxation times in schizophrenia as measured with magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

MRI T2 relaxation times of brain regions in schizophrenic patients and control subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Brain gray and white matter transverse relaxation time in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Tract-based analysis of magnetization transfer ratio and diffusion tensor imaging of the frontal and frontotemporal connections in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Comparing free water imaging and magnetization transfer measurements in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Gray and white matter brain abnormalities in first-episode schizophrenia inferred from magnetization transfer imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Neuropathological abnormalities in schizophrenia: evidence from magnetization transfer imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

DTI and MTR abnormalities in schizophrenia: analysis of white matter integrity.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

A magnetization transfer analysis of the thalamus in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

The extent of diffusion MRI markers of neuroinflammation and white matter deterioration in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Abnormal white matter microstructure and increased extracellular free-water in the cingulum bundle associated with delusions in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

From stress to psychosis: whom, how, when and why?

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Stress Sensitivity, Aberrant Salience, and Threat Anticipation in Early Psychosis: An Experience Sampling Study

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

The Interface of Stress and the HPA Axis in Behavioural Phenotypes of Mental Illness

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Elevated inflammation levels in depressed adults with a history of childhood maltreatment

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Longitudinal in vivo maturational changes of metabolites in the prefrontal cortex of rats exposed to polyinosinic-polycytidylic acid in utero.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Microglial activation in the rat brain following chronic antipsychotic treatment at clinically relevant doses

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Haloperidol and olanzapine mediate metabolic abnormalities through different molecular pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Microglia in health and pain: impact of noxious early life events.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Crosstalk between the nociceptive and immune systems in host defence and disease

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Long-term impact of systemic bacterial infection on the cerebral vasculature and microglia.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Effects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behavior

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Translocator protein (TSPO 18kDa) is expressed by neural stem and neuronal precursor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Imaging robust microglial activation after lipopolysaccharide administration in humans with PET.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Repeated Social Defeat, Neuroinflammation, and Behavior: Monocytes Carry the Signal.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Glial cells as drug targets: What does it take?

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Critical data-based re-evaluation of minocycline as a putative specific microglia inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Does minocycline have antidepressant effect?

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930101-3

7 January 2021

10.1016/S2215-0366(17)30101-3

Identifiers

DOI

1 reference

5 September 2017

1 reference

PubMed ID

28454915